Clinical-stage biotech company Oncolytics Biotech Inc. ... Kazia Therapeutics Limited (NASDAQ: KZIA) presented new data at the 2025 San Antonio ...
News
- How $594B in Precision Tech is Cracking the Metastatic Cancer Code | INN
- Positive Kisqali data will help Novartis take the fight to Pfizer - The Pharma Letter
More on this story... Novartis expands in gene therapy and neuroscience with $8.7 billion ...
- CCNY undergrads produce five-star performance at annual national STEM conference
... Biomedical Research Conference for Minoritized Scientists (ABRCMS) in San Antonio, Texas. The conference attracted close to 5000 participants ...
- The $170B Survival Race: Why Big Pharma is Snapping Up Late-Stage Cancer Tech
Oncolytics Biotech Inc. (NASDAQ: ONCY), OS Therapies Inc. (NYSE-A ... San Antonio Breast Cancer Symposium, demonstrating compelling efficacy ...
- Ph.D. in Molecular Bioscience - YouTube
Go to channel Graduate School of Biomedical Sciences at UT Health San Antonio. Molecular Immunology & Microbiology Discipline of the Integrated ...